Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
Aiping Zhang, Kai Miao, Heng Sun, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 3019-3033
Open Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance
Xu Guo, Congying Gao, Dong‐Hua Yang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100937-100937
Closed Access | Times Cited: 99
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
Zhenduo Shi, Kun Pang, Zhuo‐Xun Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 94
Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies
Mohamed El‐Tanani, Syed Arman Rabbani, Rasha Babiker, et al.
Cancer Letters (2024) Vol. 591, pp. 216894-216894
Open Access | Times Cited: 46
The significant role of amino acid metabolic reprogramming in cancer
Xiaohong Liu, Bo Ren, Jie Ren, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Tumor microenvironment as a complex milieu driving cancer progression: a mini review
Zhengrui Li, Jing Li, Xiaolei Bai, et al.
Clinical & Translational Oncology (2024)
Open Access | Times Cited: 16
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 10
Molecular principles underlying aggressive cancers
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Advancing Optical Nanosensors with Artificial Intelligence: A Powerful Tool to Identify Disease-Specific Biomarkers in Multi-omics Profiling
Bakr Ahmed Taha, Zahraa Mustafa Abdulrahm, Ali J. Addie, et al.
Talanta (2025) Vol. 287, pp. 127693-127693
Closed Access | Times Cited: 2
Harnessing Engineered Immune Cells and Bacteria as Drug Carriers for Cancer Immunotherapy
Jingwen Jiang, Yanjuan Huang, Zishan Zeng, et al.
ACS Nano (2023) Vol. 17, Iss. 2, pp. 843-884
Closed Access | Times Cited: 28
Advancing drug-response prediction using multi-modal and -omics machine learning integration (MOMLIN): a case study on breast cancer clinical data
Md Mamunur Rashid, Kumar Selvarajoo
Briefings in Bioinformatics (2024) Vol. 25, Iss. 4
Open Access | Times Cited: 10
Single-cell transcriptomic analyses of tumor microenvironment and molecular reprograming landscape of metastatic laryngeal squamous cell carcinoma
Yuanyuan Sun, Sheng Chen, Yongping Lu, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 9
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 9
Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysis
Francisco Cézar Aquino de Moraes, Maria Eduarda Cavalcanti Souza, Vitor Kendi Tsuchiya Sano, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 9
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy
Yasaman Zohrab Beigi, Hossein Lanjanian, Reyhane Fayazi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 8
Precision medicine in gynecological cancer (Review)
Aikaterini Aravantinou‐Fatorou, Vasiliki Georgakopoulou, Meletios Α. Dimopoulos, et al.
Biomedical Reports (2025) Vol. 22, Iss. 3
Open Access | Times Cited: 1
GNA15 predicts poor outcomes as a novel biomarker related to M2 macrophage infiltration in ovarian cancer
Qin Liu, Yabing Sun, Tao Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
A Multiple Stimuli-Responsive NanoCRISPR Overcomes Tumor Redox Heterogeneity to Augment Photodynamic Therapy
Jin Yang, Liping Bai, Meiling Shen, et al.
ACS Nano (2023) Vol. 17, Iss. 12, pp. 11414-11426
Closed Access | Times Cited: 18
3D bioprinting tumor models mimic the tumor microenvironment for drug screening
Xuelian Mi, Zhi Yi Su, Xiaokun Yue, et al.
Biomaterials Science (2023) Vol. 11, Iss. 11, pp. 3813-3827
Closed Access | Times Cited: 16
Exosomes‐mediated crosstalk between glioma and immune cells in the tumor microenvironment
Xu Guo, Rui Sui, Haozhe Piao
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 8, pp. 2074-2085
Open Access | Times Cited: 16
Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp
Mohamad Ali Hijazi, André Gessner, Nahed El‐Najjar
Cancers (2023) Vol. 15, Iss. 12, pp. 3199-3199
Open Access | Times Cited: 16
CD147: an integral and potential molecule to abrogate hallmarks of cancer
Alphonce M. K. Nyalali, Angela U. Leonard, Yongxiang Xu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Exploring a specialized programmed-cell death patterns to predict the prognosis and sensitivity of immunotherapy in cutaneous melanoma via machine learning
Leyang Xiao, Ruifeng He, Kaibo Hu, et al.
APOPTOSIS (2024) Vol. 29, Iss. 7-8, pp. 1070-1089
Closed Access | Times Cited: 6
Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance
Shikshya S. Panda, Rajeev Kumar Sahoo, Sambit K. Patra, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104061-104061
Closed Access | Times Cited: 6
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer
Daniele Fanale, Alessandra Dimino, Erika Pedone, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4344-4344
Open Access | Times Cited: 26
DRMref: comprehensive reference map of drug resistance mechanisms in human cancer
Xiaona Liu, Jiahao Yi, Tina Li, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1253-D1264
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top